ClinicalTrials.gg
Sign In

Lymphoma, B-Cell clinical trials

The registry lists 885 studies for Lymphoma, B-Cell across more than 10 countries. 286 are recruiting or about to start. 539 of them are mainly about Lymphoma, B-Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 5 narrower conditions too, such as Lymphoma, Large B-Cell, Diffuse: 3,245 studies, 786 open.

ClinicalTrials.gov finds 4,727 studies for Lymphoma, B-Cell. How that becomes 885 here

This page counts the studies the registry files under Lymphoma, B-Cell, and those it files under no condition that list Lymphoma, B-Cellthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 4,727Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −2,350Filed under a narrower condition, counted on its own pageLymphoma, Large B-Cell, Diffuse 1,673 · Burkitt Lymphoma 361 · Lymphoma, B-Cell, Marginal Zone 260 · Lymphoma, AIDS-Related 20 · Lymphomatoid Granulomatosis 2
  3. −146List Lymphoma, B-Cell as a condition, but the registry did not file them under itMost often written as “DLBCL - Diffuse Large B Cell Lymphoma” (36), “Large B-cell Lymphoma” (14), and “Non-hodgkin Lymphoma,B Cell” (8). The registry filed them under other conditions only, most often Dendritic Cell Sarcoma, Interdigitating (43) and Recurrence (35).
  4. −1,346Match it another way182 name it in the title, 19 in a keyword, and 1,145 by a synonym or other text the search reads.
  5. 885The count on this page105 of them list Lymphoma, B-Cell in their own words; the registry filed them under no condition.

Get an email when these change. Save the Lymphoma, B-Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
255
Recruiting
209
Status unknown
111
Active, not recruiting
95
Terminated
91
Not yet recruiting
70

Phase

Phase 1
458
Phase 2
387
Early Phase 1
42
Phase 3
42
Phase 4
11

Where

United States
398
China
283
France
94
Italy
65
United Kingdom
64
Australia
63

Who runs them

National Cancer Institute (NCI) (27) · M.D. Anderson Cancer Center (26) · Ruijin Hospital (18) · AstraZeneca (12) · Fred Hutchinson Cancer Center (11) · Institute of Hematology & Blood Diseases Hospital, China (10) · The Lymphoma Academic Research Organisation (10) · Mayo Clinic (9)

What is being tested here

Drugs under test in Lymphoma, B-Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Chimeric Antigen Receptor T-cells8113
Cyclophosphamide7128
Rituximab6651
Relmacabtagene autoleucel505
Glofitamab407
Zamtocabtagene autoleucel404
Fludarabine3016
Lenalidomide3016
Etoposide3112
Pirtobrutinib3610

Drug classes tested here Alkylating agents 10 open · Tyrosine kinase inhibitors (TKIs) 7 open · Antimetabolites 6 open · Immune checkpoint inhibitors 4 open · Antibody-drug conjugates (ADCs) 4 open

Coming up

19phase 3 studies under way
111studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 209 Lymphoma, B-Cell studies recruiting now, 129 (62%) set no upper age limit and 60 (29%) stop at 75 or younger. 37 (18%) take children under 18. 1 (<1%) are for women only and 0 (0%) for men only; 3 (1%) take healthy volunteers.

Recruiting studies that take each age, of 209
AgeWomenMen
1025 (12%)25 (12%)
18199 (95%)198 (95%)
30200 (96%)199 (95%)
40197 (94%)196 (94%)
50197 (94%)196 (94%)
65200 (96%)199 (95%)
75190 (91%)189 (90%)
85137 (66%)136 (65%)

Across all 885 studies, recruiting or not: 30% stop at 75 or younger and 7% at 65; 15% take children; <1% are for women only and <1% for men only; 1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Lymphoma, B-Cell studies take

Of 207 phase 1 interventional studies under Lymphoma, B-Cell, half reached primary completion within 51 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 151 mo37–78 · 207 studies47 mo37–81 · 90 studies54 mo37–75 · 117 studies
Phase 1/271 mo55–96 · 94 studies—64 mo45–82 · 52 studies
Phase 255 mo34–77 · 122 studies—61 mo37–81 · 96 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting3

Results posted3

Stopped2

Newly registered9

Show 4 more

Studies

Recruiting first, then most recently updated. Showing 50 of 885. Browse all 885 → or search them.